PTPI (Petros Pharmaceuticals, Inc.) Koefisien nilai perusahaan marang pendapatan

Petros Pharmaceuticals Inc (PTPI) - logo korporat

Petros Pharmaceuticals (PTPI) relies on a closed B2B distribution network for urological products, which guarantees market stability. This EV/Sales chart demonstrates valuation dynamics, where the value captures the metric level. The optimization of confidential prescription drug delivery reduces costs, while independence from global macroeconomic cycles transforms the company into a reliable defensive asset.

Petros Pharmaceuticals, Inc. - Rasio nilai perusahaan marang pendapatan PTPI (periode 04.07.2022 - 20.11.2026)

Rincian metrik keuangan lan pasar Petros (PTPI)

Analisis wiwitan perusahaan:Petros Pharmaceuticals
Produk asli Petros Pharmaceuticals Inc

This multiple compares the total enterprise value with the volume of generated sales, excluding the impact of debt load to identify the real market value of assets. An analysis of the valuation of Petros Pharmaceuticals (PTPI) based on revenue excluding debt allows for the separation of the company's operational efficiency from financial fluctuations, confirming business resilience through the full localization of logistics and the protection of supply chains within the US.

Analisis pesaing Petros Pharmaceuticals

HLN: Rasio nilai perusahaan marang pendapatan|Kenvue Corp (KVUE) - Rasio nilai perusahaan marang pendapatan|Verona Pharma PLC - Nilai bisnis marang pendapatan|Rasio nilai perusahaan marang pendapatan Jyong Biotech Ltd|Multiplikator EV/Sales Ligand Corp|Multiplikator EV/Sales AMRX|Rasio total nilai perusahaan marang pendapatan Perrigo Company plc|Multiplikator EV/Sales ALVO (Alvotech Biopharmaceuticals)|LQDA: Rasio nilai perusahaan marang pendapatan|Galapagos N.V. - Multiplikator EV/Sales|ANIP - Multiplikator EV/Sales|MNKD: Multiplikator EV/Sales|amphastar.com (AMPH) - Multiplikator EV/Sales|PCRX (Pacira Pharmaceuticals) - Multiplikator EV/Sales|Nilai perusahaan marang pendapatan ARS Pharmaceuticals, Inc. (SPRY)|Multiplikator EV/Sales TBPH|AQST (Aquestive Therapeutics) - Nilai bisnis marang pendapatan|scPharmaceuticals, Inc. - Nilai perusahaan marang pendapatan|Nilai bisnis marang pendapatan TECX|tonixpharma.com - Multiplikator EV/Sales|Nilai bisnis marang pendapatan SXTC (sxtchina.com)|Eupraxia Pharma (EPRX) - Rasio nilai perusahaan marang pendapatan|Nilai perusahaan marang pendapatan BioHarvest|Nilai perusahaan marang pendapatan EXOZ|Nilai perusahaan marang pendapatan Oramed Pharmaceuticals (ORMP)|Nilai perusahaan marang pendapatan ENTX (Entera Bio Corp)|MindWalk Holdings Inc. - Rasio nilai perusahaan marang pendapatan|Multiplikator EV/Sales ABVC (ABVC BioPharma Inc)|CPIX - Nilai perusahaan marang pendapatan|Quantum BioPharma Corp - Multiplikator EV/Sales|FGEN (fibrogen.com) - Rasio nilai perusahaan marang pendapatan|TELO (Telomir Pharmaceuticals) - Nilai perusahaan marang pendapatan|Rani Therapeutics Holdings - Nilai bisnis marang pendapatan|Nilai perusahaan marang pendapatan SNYR|Multiplikator nilai perusahaan marang pendapatan rallybio.com RLYB|Multiplikator EV/Sales LEXX|PULM (Pulmatrix, Inc.) - Nilai bisnis marang pendapatan|Pheton Holdings - Nilai perusahaan marang pendapatan|Multiplikator EV/Sales Aptorum Group Limited APM|LYRA: Nilai perusahaan marang pendapatan|IBO: Rasio nilai perusahaan marang pendapatan|TNFA: Multiplikator EV/Sales|YCBD: Koefisien nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan PainReform Ltd|CYTO (altamiratherapeutics.com) - Koefisien nilai perusahaan marang pendapatan|Multiplikator EV/Sales LIPO|OPTN - Multiplikator nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan pieris.com PIRS|Nilai bisnis marang pendapatan PROC|QLI - Rasio nilai perusahaan marang pendapatan|Nilai bisnis marang pendapatan SLRN (ACELYRIN)|TFF Pharmaceuticals, Inc (TFFP) - Rasio nilai perusahaan marang pendapatan